EXCERPTS: A batch of new drugs that aim to clear the gunk out of the brains of Alzheimer's patients are providing the best hope yet that it might be possible to slow the disease.


But they're not even close to being a cure, experts said — and they're also not close to being on the market.


And, researchers admit, the benefits they see amount to numbers on a graph, not anything that patients or their loved ones might notice.


Researchers reported on the trials of three experimental drugs that use immune system weapons called monoclonal antibodies to clear the brain-clogging protein called amyloid. READ MORE ->

Attachments
REBEL!
Back To Top
TOP